Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hormone replacement therapy for postmenopausal osteoporosis.

Ann Cranney1, George A Wells

  • 1Division of Rheumatology, Department of Medicine, Queen's University, Etherington Hall, Room 2004, 94 Stuart Street, Kingston, Ontario, Canada, K7L 3N4. cranneya@kgh.kari.net

Clinics in Geriatric Medicine
|August 15, 2003
PubMed
Summary

Hormone replacement therapy (HRT) effectively improves bone density and reduces fracture risk. However, its unfavorable risk/benefit profile limits use for osteoporosis prevention due to safer alternatives.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Physician questions and concerns related to COVID-19: a content analysis of advice calls to a medico-legal helpline.

CMAJ open·2022
Same author

Quality and transparency of reporting derivation and validation prognostic studies of recurrent stroke in patients with TIA and minor stroke: a systematic review.

Diagnostic and prognostic research·2022
Same author

Vitamin D and Chronic Diseases among First-Generation Immigrants: A Large-Scale Study Using Canadian Health Measures Survey (CHMS) Data.

Nutrients·2022
Same author

Risedronate for the primary and secondary prevention of osteoporotic fractures in postmenopausal women.

The Cochrane database of systematic reviews·2022
Same author

Utility of a smartphone application in assessing palmar circulation prior to radial artery harvesting for coronary artery bypass grafting: rationale and design of the randomised CAPITAL iRADIAL-CABG trial.

BMJ open·2022
Same author

Randomized Ablation-Based Rhythm-Control Versus Rate-Control Trial in Patients With Heart Failure and Atrial Fibrillation: Results from the RAFT-AF trial.

Circulation·2022

Area of Science:

  • Endocrinology
  • Bone Metabolism
  • Geriatric Medicine

Background:

  • Osteoporosis is a significant public health concern, characterized by low bone density and increased fracture risk.
  • Hormone replacement therapy (HRT) has been investigated for its potential role in osteoporosis management.
  • The Women's Health Initiative (WHI) study provided crucial data on HRT's effects.

Purpose of the Study:

  • To clarify the role of HRT in osteoporosis prevention based on recent WHI findings.
  • To evaluate the impact of HRT on bone density and fracture reduction.
  • To assess the risk/benefit profile of HRT for osteoporosis prevention.

Main Methods:

  • Analysis of data from randomized controlled trials (RCTs) and observational studies.
  • Evaluation of bone mineral density at cortical and trabecular sites.

Related Experiment Videos

  • Assessment of vertebral and hip fracture incidence in relation to HRT use.

    • Main Results:

    • Consistent RCT data demonstrate HRT's efficacy in improving bone density at various skeletal sites, showing a dose-response relationship.
    • Both RCT and observational data support HRT's positive effect on reducing vertebral and hip fractures.
    • Despite efficacy, HRT presents an unfavorable risk/benefit profile for osteoporosis prevention.

    Conclusions:

    • HRT effectively enhances bone density and reduces fracture risk, particularly vertebral and hip fractures.
    • The unfavorable risk/benefit ratio of HRT restricts its application in osteoporosis prevention.
    • Alternative medications with demonstrated fracture efficacy are preferred for osteoporosis management.